Not applicableUnknownNCT02892630What this trial is testingImmune Thrombocytopenia in PregnancyWho this might be right forImmune ThrombocytopeniaPregnancy Assistance Publique - Hôpitaux de Paris 300
Large-scale testing (Phase 3)Study completedNCT01662531What this trial is testingA Safety, Efficacy and Pharmacokinetics Study of a Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Children With Hemophilia BWho this might be right forHemophilia B CSL Behring 27
Not applicableStudy completedNCT00344435What this trial is testingGenetic Susceptibility to Factor VIII InhibitorsWho this might be right forHemophilia National Cancer Institute (NCI) 1,187
Not applicableStudy completedNCT04372173What this trial is testingAn Evaluation of Clotting Factor Activity Before and After Total Hip ArthroplastyWho this might be right forArthroplasty, ReplacementCoagulation Factors Military Institute od Medicine National Research Institute 30
Early research (Phase 1)Study completedNCT06517563What this trial is testingEffects of VMX-C001 on the Anticoagulant Effect of Different Forms of HeparinWho this might be right forCoagulation Disorder VarmX B.V. 16
Not applicableLooking for participantsNCT07099313What this trial is testingAssociation of Prophylactic Treatment With Treatment Burden and Psychosocial Variables in Patients With HemophiliaWho this might be right forHemophilia Investigación en Hemofilia y Fisioterapia 114
Testing effectiveness (Phase 2)Study completedNCT03205163What this trial is testingA Safety, Tolerability, and Pharmacokinetics Study of a Single Intravenous Injection of Recombinant Coagulation Factor VIII Fc - Von Willebrand Factor - XTEN Fusion Protein (rFVIIIFc-VWF-XTEN) (BIVV001) in Previously Treated Adults With Severe Hemophilia A (EXTEN-A)Who this might be right forHemophilia A Bioverativ, a Sanofi company 16
Not applicableStudy completedNCT01602445What this trial is testingPro-coagulant Markers and Anticoagulant Failure in Cancer Patients at Risk for Recurrence of Venous ThromboembolismWho this might be right forVenous ThromboembolismDeep-Vein ThrombosisPulmonary Embolism+1 more Ottawa Hospital Research Institute 700
Not applicableStudy completedNCT03634215What this trial is testingEstimation of Coagulation Factor XIII Activity Based on the Initial Plasma Fibrinogen Level in TraumaWho this might be right forMultiple TraumaCoagulation DisorderCoagulation Factor Deficiency+1 more Masaryk Hospital Krajská zdravotní a.s. 357
Not applicableStudy completedNCT03818529What this trial is testingATHN 8: Previously Untreated Patients (PUPs) Matter StudyWho this might be right forHemophiliaHemophilia AHemophilia B+5 more American Thrombosis and Hemostasis Network 237
Early research (Phase 1)Study completedNCT02470871What this trial is testingStudy of the Pharmacokinetics and Safety of Recombinant Factor VIIa Fusion Protein (rVIIa-FP, CSL689) in Patients With Congenital Factor VII DeficiencyWho this might be right forCongenital Coagulation Factor VII Deficiency CSL Behring 9
Large-scale testing (Phase 3)Study completedNCT00162019What this trial is testingPharmacokinetics, Efficacy and Safety Study of IMMUNATE SD (Human Plasma-Derived Coagulation Factor VIII Concentrate) in Hemophilia A PatientsWho this might be right forHemophilia A Baxalta now part of Shire 56
Large-scale testing (Phase 3)Active Not RecruitingNCT04644575What this trial is testingLong-term Safety and Efficacy of Efanesoctocog Alfa (BIVV001) in Previously Treated Patients With Hemophilia AWho this might be right forHemophilia A Bioverativ, a Sanofi company 261
Large-scale testing (Phase 3)Active Not RecruitingNCT05817812What this trial is testingA Study Evaluating Physical Activity and Joint Health in Severe Haemophilia A Patients ≥12 Years Treated Once Weekly With Efanesoctocog AlfaWho this might be right forHemophilia A, Severe Swedish Orphan Biovitrum 93
Large-scale testing (Phase 3)Study completedNCT00243243What this trial is testingEffect of rFVIIa on Peri-operative Blood Loss in Patients Undergoing Major BurnWho this might be right forBurns United States Army Institute of Surgical Research 20
Early research (Phase 1)Study completedNCT04864743What this trial is testingEvaluate the Pharmacokinetics，Safety and Tolerability of PEG Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for InjectionWho this might be right forSevere Hemophilia A Hangzhou Gensciences Biopharmaceutical Co., Ltd. 13
Large-scale testing (Phase 3)Study completedNCT01458106What this trial is testingStudy to Evaluate the Safety, Efficacy, and Pharmacokinetics of Recombinant Coagulation Factor VIII Fc Fusion Protein (rFVIIIFc) in Previously Treated Pediatric Subjects With Hemophilia AWho this might be right forHemophilia A Bioverativ Therapeutics Inc. 71
Early research (Phase 1)UnknownNCT04768699What this trial is testingStudy of Recombinant Human Coagulation Factor VIIa for Injection (FⅦa) in Patients With Hemophilia.Who this might be right forHemophilia A With InhibitorHemophilia B With Inhibitor Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 24
Not applicableStudy completedNCT05037604What this trial is testingFactors Associated With DermatoporosisWho this might be right forSenile Purpura Universidad Autonoma de San Luis Potosí 315
Not applicableStudy completedNCT03421184What this trial is testingDietary Phytoestrogens as Risk Factors for Systemic Lupus ErythematosusWho this might be right forLupus ErythematosusRheumatoid ArthritisAutoimmune Thrombocytopenia University Hospital, Bordeaux 63